[HTML][HTML] Dabigatran for Japanese patients with atrial fibrillation and prior stroke: a subgroup analysis of the J-Dabigatran Surveillance program
M Yasaka, S Uchiyama, H Atarashi, K Okumura… - Journal of Stroke and …, 2020 - Elsevier
Background: The study objective was to evaluate long-term safety and effectiveness of
dabigatran 110 mg and 150 mg twice daily (bid) in patients with nonvalvular atrial fibrillation …
dabigatran 110 mg and 150 mg twice daily (bid) in patients with nonvalvular atrial fibrillation …
Dabigatran for Japanese Patients with Atrial Fibrillation and Prior Stroke: A Subgroup Analysis of the J-Dabigatran Surveillance Program.
M Yasaka, S Uchiyama, H Atarashi… - Journal of Stroke and …, 2020 - europepmc.org
BACKGROUND: The study objective was to evaluate long-term safety and effectiveness of
dabigatran 110 mg and 150 mg twice daily (bid) in patients with nonvalvular atrial fibrillation …
dabigatran 110 mg and 150 mg twice daily (bid) in patients with nonvalvular atrial fibrillation …
Dabigatran for Japanese Patients with Atrial Fibrillation and Prior Stroke: A Subgroup Analysis of the J-Dabigatran Surveillance Program
M Yasaka, S Uchiyama, H Atarashi… - Journal of stroke …, 2020 - pubmed.ncbi.nlm.nih.gov
Background The study objective was to evaluate long-term safety and effectiveness of
dabigatran 110 mg and 150 mg twice daily (bid) in patients with nonvalvular atrial fibrillation …
dabigatran 110 mg and 150 mg twice daily (bid) in patients with nonvalvular atrial fibrillation …
[HTML][HTML] Dabigatran for Japanese Patients with Atrial Fibrillation and Prior Stroke: A Subgroup Analysis of the J-Dabigatran Surveillance Program
M Yasaka, S Uchiyama, H Atarashi… - Journal of Stroke and …, 2020 - strokejournal.org
Background: The study objective was to evaluate long-term safety and effectiveness of
dabigatran 110 mg and 150 mg twice daily (bid) in patients with nonvalvular atrial fibrillation …
dabigatran 110 mg and 150 mg twice daily (bid) in patients with nonvalvular atrial fibrillation …